Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT07128004
Eligibility Criteria:
Inclusion Criteria:
* The presence of tinnitus (persistent sound heard in one or both ears that is not coming from an external sound source or actual sounds being generated inside your body such as turbulent blood flow), which has persisted for at least 3 days, and began within the last 8 weeks. You do not need to be aware of the tinnitus all the time, but it must be persistent in the sense that is can always hear it if you listen out for it, and there is not enough other sounds around to mask it.
* Age 18 or over
* The ability to make and communicate an informed choice about whether to take part in the study
* The ability to sit still and comfortably in a comfortable chair for around 1 hour at a time.
Exclusion Criteria:
* Tinnitus due to a physical sound source in the body, such as turbulent blood flow or muscle contractions in the middle ear.
* Presence of tinnitus over a period of 8 weeks
* Severe or profound hearing loss at high frequencies in the tinnitus ear(s), such that you could not properly hear the sounds used in the study
* Any implanted electronic device, such as a pacemaker, cochlear implant, bone-anchored hearing aid, nerve stimulator, deep brain stimulator or spinal cord stimulator
* Any areas of broken skin on the parts of the scalp where tDCS is applied
* Ménière's disease
* Any abnormality of brain structure (e.g. stroke, tumour), or other neurological disorder (e.g. multiple sclerosis or epilepsy)
* The ongoing use of sedating medications, or certain other nerve- or brain-acting medications
* A current mental health condition of sufficient severity to prevent certain activities of everyday life
In addition to these criteria, the researcher might have other reasons to suspect that participation is either contraindicated, or might be unsuitable. In such cases, the researcher should discuss these concerns with the potential participant and/or a senior member of the research team. Participation should only proceed if all those involved in these discussions agree it should.
\-
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07128004
Study Brief:
Protocol Section:
NCT07128004